224 related articles for article (PubMed ID: 23647854)
1. Kinetic analyses of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid transport in Xenopus laevis oocytes expressing human ASCT2 and SNAT2.
Okudaira H; Nakanishi T; Oka S; Kobayashi M; Tamagami H; Schuster DM; Goodman MM; Shirakami Y; Tamai I; Kawai K
Nucl Med Biol; 2013 Jul; 40(5):670-5. PubMed ID: 23647854
[TBL] [Abstract][Full Text] [Related]
2. Putative transport mechanism and intracellular fate of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid in human prostate cancer.
Okudaira H; Shikano N; Nishii R; Miyagi T; Yoshimoto M; Kobayashi M; Ohe K; Nakanishi T; Tamai I; Namiki M; Kawai K
J Nucl Med; 2011 May; 52(5):822-9. PubMed ID: 21536930
[TBL] [Abstract][Full Text] [Related]
3. [(14)C]Fluciclovine (alias anti-[(14)C]FACBC) uptake and ASCT2 expression in castration-resistant prostate cancer cells.
Ono M; Oka S; Okudaira H; Nakanishi T; Mizokami A; Kobayashi M; Schuster DM; Goodman MM; Shirakami Y; Kawai K
Nucl Med Biol; 2015 Nov; 42(11):887-92. PubMed ID: 26278491
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of transport mechanisms of trans-1-amino-3-[¹⁸F]fluorocyclobutanecarboxylic acid and L-[methyl-¹¹C]methionine in human glioma cell lines.
Ono M; Oka S; Okudaira H; Schuster DM; Goodman MM; Kawai K; Shirakami Y
Brain Res; 2013 Oct; 1535():24-37. PubMed ID: 23994214
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Amino Acid/Drug Transporters for Renal Transport of [
Ono M; Baden A; Okudaira H; Kobayashi M; Kawai K; Oka S; Yoshimura H
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754421
[TBL] [Abstract][Full Text] [Related]
6. Transport mechanisms of trans-1-amino-3-fluoro[1-(14)C]cyclobutanecarboxylic acid in prostate cancer cells.
Oka S; Okudaira H; Yoshida Y; Schuster DM; Goodman MM; Shirakami Y
Nucl Med Biol; 2012 Jan; 39(1):109-19. PubMed ID: 21958853
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of trans-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid in prostate cancer due to androgen-induced expression of amino acid transporters.
Okudaira H; Oka S; Ono M; Nakanishi T; Schuster DM; Kobayashi M; Goodman MM; Tamai I; Kawai K; Shirakami Y
Mol Imaging Biol; 2014 Dec; 16(6):756-64. PubMed ID: 24943499
[TBL] [Abstract][Full Text] [Related]
8. Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth.
Bothwell PJ; Kron CD; Wittke EF; Czerniak BN; Bode BP
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30029480
[TBL] [Abstract][Full Text] [Related]
9. The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).
Cormerais Y; Massard PA; Vucetic M; Giuliano S; Tambutté E; Durivault J; Vial V; Endou H; Wempe MF; Parks SK; Pouyssegur J
J Biol Chem; 2018 Feb; 293(8):2877-2887. PubMed ID: 29326164
[TBL] [Abstract][Full Text] [Related]
10. Transport of a neurotoxicant by molecular mimicry: the methylmercury-L-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2.
Simmons-Willis TA; Koh AS; Clarkson TW; Ballatori N
Biochem J; 2002 Oct; 367(Pt 1):239-46. PubMed ID: 12117417
[TBL] [Abstract][Full Text] [Related]
11. Cloning and functional characterization of a system ASC-like Na+-dependent neutral amino acid transporter.
Utsunomiya-Tate N; Endou H; Kanai Y
J Biol Chem; 1996 Jun; 271(25):14883-90. PubMed ID: 8662767
[TBL] [Abstract][Full Text] [Related]
12. Amino acid transporter expression and 18F-FACBC uptake at PET in primary prostate cancer.
Tulipan AJ; Salberg UB; Hole KH; Vlatkovic L; Aarnes EK; Revheim ME; Lyng H; Seierstad T
Am J Nucl Med Mol Imaging; 2021; 11(4):250-259. PubMed ID: 34513278
[TBL] [Abstract][Full Text] [Related]
13. Comparison of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid (anti-[18F]FACBC) accumulation in lymph node prostate cancer metastasis and lymphadenitis in rats.
Kanagawa M; Doi Y; Oka S; Kobayashi R; Nakata N; Toyama M; Shirakami Y
Nucl Med Biol; 2014 Aug; 41(7):545-51. PubMed ID: 24816330
[TBL] [Abstract][Full Text] [Related]
14. Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET.
Wiriyasermkul P; Nagamori S; Tominaga H; Oriuchi N; Kaira K; Nakao H; Kitashoji T; Ohgaki R; Tanaka H; Endou H; Endo K; Sakurai H; Kanai Y
J Nucl Med; 2012 Aug; 53(8):1253-61. PubMed ID: 22743251
[TBL] [Abstract][Full Text] [Related]
15. Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells.
Bröer A; Rahimi F; Bröer S
J Biol Chem; 2016 Jun; 291(25):13194-205. PubMed ID: 27129276
[TBL] [Abstract][Full Text] [Related]
16. Ablation of the
Bröer A; Gauthier-Coles G; Rahimi F; van Geldermalsen M; Dorsch D; Wegener A; Holst J; Bröer S
J Biol Chem; 2019 Mar; 294(11):4012-4026. PubMed ID: 30635397
[TBL] [Abstract][Full Text] [Related]
17. Trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid (anti-18F-FACBC) is a feasible alternative to 11C-methyl-L-methionine and magnetic resonance imaging for monitoring treatment response in gliomas.
Sasajima T; Ono T; Shimada N; Doi Y; Oka S; Kanagawa M; Baden A; Mizoi K
Nucl Med Biol; 2013 Aug; 40(6):808-15. PubMed ID: 23701701
[TBL] [Abstract][Full Text] [Related]
18. Interaction of the neutral amino acid transporter ASCT2 with basic amino acids.
Ndaru E; Garibsingh RA; Zielewicz L; Schlessinger A; Grewer C
Biochem J; 2020 Apr; 477(8):1443-1457. PubMed ID: 32242892
[TBL] [Abstract][Full Text] [Related]
19. The l-isomer-selective transport of aspartic acid is mediated by ASCT2 at the blood-brain barrier.
Tetsuka K; Takanaga H; Ohtsuki S; Hosoya K; Terasaki T
J Neurochem; 2003 Nov; 87(4):891-901. PubMed ID: 14622120
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress increases SNAT1 expression and stimulates cysteine uptake in freshly isolated rat cardiomyocytes.
King N; Lin H; Suleiman MS
Amino Acids; 2011 Feb; 40(2):517-26. PubMed ID: 20602128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
